Clinical Trial Update: Pramipexole to Enhance Social Connections [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating pramipexole to enhance social connections in individuals with anxiety disorders and depression; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Major Depressive Disorder

Drugs mentioned

• Pramipexole (pramipexole)

Snippet

Sponsor: University of California, San Diego | Conditions: Anxiety Disorders, Anxiety | Phase 2 | Status: RECRUITING